EOLS - NASDAQ

Evolus, Inc.

EOLS·NASDAQ

$6.03

-2.3%

HealthcareDrug Manufacturers - Specialty & Generic

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$397.10M

EPS-0.8000

P/E Ratio-7.54

Earnings Date08/04/2026

eols

Net Receivables

Last Annual Value

54.70M

3-Year CAGR

35%

5-Year CAGR

41%

10-Year CAGR

Adjust for Inflation

Evolus, Inc. Competitors Analysis of Net Receivables

EOLS · NASDAQ

Company	Net Receivables	CAGR 3Y	CAGR 5Y	CAGR 10Y
Evolus, Inc. NASDAQ:EOLS	54.70M	21.5%	30.1%	N/A
Neurogene Inc. NASDAQ:NGNE	0.00	N/A	N/A	N/A
Treace Medical Concepts, Inc. NASDAQ:TMCI	42.16M	3.5%	17.8%	N/A
CeriBell, Inc. NASDAQ:CBLL	15.05M	23.7%	N/A	N/A
Quantum-Si incorporated NASDAQ:QSI	561.00K	15.1%	N/A	N/A
Enhabit, Inc. NYSE:EHAB	144.00M	-4.4%	-2.6%	N/A
Solid Biosciences Inc. NASDAQ:SLDB	0.00	N/A	N/A	N/A
OrthoPediatrics Corp. NASDAQ:KIDS	53.84M	15.9%	24.6%	29.4%
The Oncology Institute, Inc. NASDAQ:TOI	59.32M	11.4%	22.8%	N/A

Evolus, Inc. Fair Value Envelope

EOLS · NASDAQ

Our analysis suggests that EOLS has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $6.03, this represents a potential HIDDEN relative to our calculated worth for Evolus, Inc..

HIDDEN

Intrinsic Value

Current Price: $6.03

Related Guides

Blog Categories

Continue your EOLS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.